HAS annual report of activities

HAS has today (2^nd July 2015) published its Annual Report for 2014.

Regarding medicinal products:

• 630 opinions were published in 2014:
  • first registration: 190 opinions (30%)
  • extension of indication: 45 opinions (7%)
  • Renewal: 184 opinions (29%)
  • Other: 211 opinions (34%)
• The median duration of evaluation was 107 days.
• In first registration, one product recevied ASMR I Orphacol), 5 products received ASMR II (Bexsero, Kadcyla, Kineret, Sovaldi, Succicaptal) and 7 products received ASMR III (Carmyne, Hemangiol, Immovid, Revlimid, Sovaldi, Tivicay, Vimizin).

Regarding medicinal devices:

• 195 opinions were published in 2014:
• first registration: 78 opinions (40%)
• modification of conditions for registration: 46 opinions (24%)
• Renewal: 58 opinions (30%)
• Other: 13 opinions (6%)
• The mean duration of evaluation was 86 days.
• In first registration, 5 medical devices recevied ASA III (Lifevest, I-limb ultra, E-vita Open plus, Thoraflex hybrid, Integra Dermal Regeneration template).

A summary of the report can be found here, or the full report can be read here (both available in French only).

Tagged with HAS

Published on 2. July 2015 in News France